Company / Inventory
Axsome Therapeutics, Inc. Inventory History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$27.9M
FY2025
5-year range
$4.3M / $27.9M
FY2022-FY2025
Trend
+77.6%
vs FY2024
Sector context
#72 of 105
Health Care
What the data says
At $28M, Axsome Therapeutics, Inc.'s inventory ranks #72 of 105 in the Health Care sector. Inventory has increased for 3 consecutive years, from $4M in FY2022 to $28M in FY2025.
Based on SEC 10-K filings.
$28M in FY2025 with a 3-year CAGR of +86.3%.
Improved from $15M to $28M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +86.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#72 of 105 in Health CareTop 69% of 105This company $27.9M Sector average $885.3M
▼
-96.8% below sector average
Key checks
Key Insights
- Axsome Therapeutics, Inc.'s inventory has grown for 3 consecutive years.
- 3-year CAGR of +86.3%, indicating consistent growth.
- In FY2025, inventory increased 77.6% year-over-year.
- Ranks #72 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.9M | +77.6% |
| FY2024 | $15.7M | +3.9% |
| FY2023 | $15.1M | +250.3% |
| FY2022 | $4.3M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026